Therapeutic Potential of Polysaccharide‐Modulated Gut Microbiota–Immune Axis in Gastrointestinal Cancers: Modern Insights From Traditional Pharmacy
Molecular Nutrition & Food Research · 2026-07 · 70 (14)
DOI: 10.1002/mnfr.70561 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Nutrition & Food Research, online erschienen am 27.07.2026. Verfasst von Hang Gao und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Integrated Chinese and Western Medicine, Anhui University of Chinese Medicine, Hefei, Anhui, P. R. China. Hauptthemen laut MEDLINE: Polysaccharides, Gastrointestinal Microbiome, Gastrointestinal Neoplasms. Die Arbeit nennt 144 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Training Action Project of Anhui Provincial Education Department of Young and Middle-aged Teachers, Anhui University of Chinese Medicine "Basic-Clinical Integration" Special Program.
Abstract (Originalsprache)
Gastrointestinal (GI) cancers are a leading cause of cancer‐related death worldwide, while drug resistance and treatment‐related toxicity continue to limit therapeutic efficacy. A growing body of evidence indicates that the gut microbiota‐immune axis (GMIA) is closely involved in the development, progression, and treatment response of GI malignancies. In this review, we summarize current understanding of how gut microbial dysbiosis and GMIA dysfunction contribute to GI cancer development and progression. We highlight the role of natural polysaccharides in modulating gut microbial composition and microbial metabolites, thereby influencing host immune responses and exerting antitumor potential in preclinical settings. In addition, we review recent advances in representative natural polysaccharides as promising candidates for the prevention and treatment of gastrointestinal cancers, with an emphasis on their translational prospects and priorities for future investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Integrated Chinese and Western Medicine, Anhui University of Chinese Medicine, Hefei, Anhui, P. R. China.
- Institute of Surgery, Anhui Academy of Chinese Medicine, Anhui University of Chinese Medicine, Hefei, Anhui, P. R. China.
- Anhui Provincial Key Laboratory of Tumor Evolution and Intelligent Diagnosis and Treatment, Bengbu, Anhui, P. R. China.
Förderung
- National Natural Science Foundation of China
- Training Action Project of Anhui Provincial Education Department of Young and Middle-aged Teachers
- Anhui University of Chinese Medicine "Basic-Clinical Integration" Special Program
- Open Project of Anhui Provincial Key Laboratory of Tumor Evolution and Intelligent Diagnosis and Treatment
- Key Project of Anhui Provincial Department of Education
Zitieren
APA
Gao, H., Sheng, Y., Ge, Y., Chen, F. Y., Zhang, Z. R., Chu, J., & Song, H. (2026). Therapeutic Potential of Polysaccharide‐Modulated Gut Microbiota–Immune Axis in Gastrointestinal Cancers: Modern Insights From Traditional Pharmacy. Molecular Nutrition & Food Research, 70(14). https://doi.org/10.1002/mnfr.70561
Vancouver
Gao H, Sheng Y, Ge Y, Chen FY, Zhang ZR, Chu J, et al. Therapeutic Potential of Polysaccharide‐Modulated Gut Microbiota–Immune Axis in Gastrointestinal Cancers: Modern Insights From Traditional Pharmacy. Molecular Nutrition & Food Research. 2026;70(14). doi:10.1002/mnfr.70561
BibTeX
@article{Gao2026,
author = {Gao, Hang and Sheng, Yu and Ge, Yang and Chen, Feng-Yuan and Zhang, Zheng-Rong and Chu, Jun and Song, Hang},
title = {Therapeutic Potential of Polysaccharide‐Modulated Gut Microbiota–Immune Axis in Gastrointestinal Cancers: Modern Insights From Traditional Pharmacy},
journal = {Molecular Nutrition & Food Research},
year = {2026},
volume = {70},
number = {14},
doi = {10.1002/mnfr.70561}
}
EUVIMED